Home All OthersDiseases and ConditionsCancer: What It Really Is, What Raises Your Risk, and How Treatment Has Changed

Cancer: What It Really Is, What Raises Your Risk, and How Treatment Has Changed

by Leo
0 comments
Cancer: What It Really Is, What Raises Your Risk, and How Treatment Has Changed

Almost everyone reading this knows someone. A parent, a colleague, a neighbour who dropped off the school run rota for a few months and came back thinner, quieter, changed. Cancer has a way of inserting itself into ordinary life without much warning, which is precisely why so much of what we say about it is either terrifying or vague.

The word covers more than 200 separate diseases. Some are caught early and cured with a short operation. Others are managed for a decade like a chronic illness. A few remain stubbornly hard to treat. Treating all of that as one story does nobody any favours, so let’s take it apart properly.

What cancer actually is

Your body makes billions of new cells every day. Each one follows instructions written in its DNA, including instructions about when to stop dividing and when to die. Cancer begins when a single cell collects enough errors in those instructions to ignore them.

That cell copies itself. The copies copy themselves. Over months or years, a cluster forms that the body’s repair and immune systems fail to shut down.

banner

One disease, or two hundred?

Breast cancer and pancreatic cancer share a name and almost nothing else. They grow at different speeds, respond to different drugs, and have wildly different survival rates. Even within one organ, the molecular profile of a tumour can vary from patient to patient, which is why two people with the same diagnosis may get completely different treatment plans.

How tumours grow and spread

A tumour needs its own blood supply, so it sends out signals that recruit new vessels. That process, angiogenesis, is one reason some cancers can be starved with targeted drugs. Later, cells can break away, travel through blood or lymph, and set up somewhere else: the bones, the liver, the lungs. That spread, metastasis, causes most cancer deaths, not the original lump.

The numbers, without the panic

The World Health Organization recorded roughly 20 million new cancer diagnoses and 9.7 million deaths worldwide in 2022. Those are enormous figures. They are also not the whole picture.

In the United States, five-year relative survival across all cancers sat around 49% in the mid-1970s. It now sits near 68%. That shift comes from earlier detection, better surgery, and drugs that didn’t exist a generation ago. Childhood leukaemia, once almost universally fatal, now has five-year survival above 85% in high-income countries. Cancer is not one long defeat.

What genuinely raises your risk

Tobacco remains the single biggest preventable cause, linked to roughly one in four cancer deaths. Beyond that, the list is longer and less discussed than most people expect.

  • Alcohol, even at moderate levels, raises risk of cancers of the mouth, throat, oesophagus, liver, colon and breast.
  • Excess body weight is linked to at least 13 cancer types, including endometrial, kidney and postmenopausal breast cancer.
  • HPV causes nearly all cervical cancers and a growing share of throat cancers; vaccination prevents most of them.
  • Hepatitis B and C drive most liver cancer cases.
  • H. pylori, a common stomach bacterium, raises gastric cancer risk and can be cleared with antibiotics.
  • Ultraviolet light from sun and tanning beds causes the majority of skin cancers.
  • Radon and air pollution account for a meaningful slice of lung cancer in people who have never smoked.

Many of these overlap with conditions that respond well to early action, which is why public health campaigns keep hammering the same handful of messages. Several of the most preventable diseases share the same underlying risk factors, and the payoff for changing them is far larger than most people assume.

The factors you can’t change

Age is the biggest single risk factor, simply because mutations accumulate over time. Inherited gene faults matter too: a BRCA1 mutation carries a lifetime breast cancer risk of roughly 55% to 72%, and Lynch syndrome sharply raises colorectal risk. Still, only 5% to 10% of cancers are strongly hereditary. Most people diagnosed have no meaningful family history at all.

Symptoms people talk themselves out of

Nobody wants to be the person who books a GP appointment over a cough. But a handful of signs are worth a conversation rather than a wait-and-see.

  • Weight loss of more than 5% over six months without trying
  • A cough, hoarseness or indigestion lasting three weeks or more
  • Blood in urine, stool, or coughed up
  • A new lump anywhere, including the neck or armpit
  • A mole changing shape, colour or size
  • Difficulty swallowing, or persistent bloating and fullness
  • Night sweats or unexplained fevers

None of these means cancer. Most turn out to be something minor. The point is that early-stage disease is usually quieter than late-stage disease, and quiet is exactly when treatment works best.

Two cancers worth knowing in detail

Prostate cancer is the most common cancer in men in many countries, with roughly one in eight diagnosed in their lifetime. It is also frequently slow-growing, which is why some men are monitored for years rather than treated immediately. The statistics, symptoms and treatment options for prostate cancer are worth understanding before a raised PSA result sends anyone into a panic.

Thyroid cancer usually appears as a painless lump at the base of the neck and generally has an excellent prognosis, with five-year survival above 98% for the most common types. Rising diagnosis rates in recent decades largely reflect better imaging picking up small tumours that might never have caused harm. A useful overview of thyroid cancer causes, symptoms and prevention explains why some of these are watched rather than operated on.

How cancer is diagnosed and staged

Imaging can suggest cancer. Only a biopsy confirms it: a pathologist looks at the cells under a microscope. Staging then describes how far it has gone, usually from I to IV, and grading describes how aggressive the cells look.

Molecular testing has become just as important. A lung tumour with an EGFR mutation responds to a completely different drug than one without it. A colorectal tumour with mismatch repair deficiency may respond dramatically to immunotherapy. Knowing the genetics of the tumour often matters more than knowing which organ it started in.

What treatment actually involves

Surgery removes disease. Radiotherapy uses precisely aimed beams, and roughly half of all cancer patients receive it at some point. Chemotherapy attacks fast-dividing cells, which is why hair and gut lining suffer alongside the tumour.

Targeted therapy blocks specific proteins driving growth. Imatinib turned chronic myeloid leukaemia from a near-certain death sentence into a condition many patients live with for decades. Immunotherapy releases the brakes on the immune system, producing long remissions in melanoma and some lung cancers that would have been untreatable fifteen years ago.

Side effects are managed far better than they used to be. Alongside anti-nausea drugs and nerve pain management, some patients use non-invasive options like TENS therapy for pain and symptom relief during treatment, always with their oncology team’s knowledge.

Living through it, not just surviving it

Fatigue is the side effect patients mention most, and it doesn’t lift with a nap. Peripheral neuropathy can leave fingers numb for years. Fertility, body image, work, childcare and money all take hits that a scan won’t show. Early palliative care, introduced alongside curative treatment rather than after it fails, has improved both quality of life and, in some trials, survival itself.

The longer-term picture matters too. Serious illness reshapes routines, relationships and identity in ways that outlast the final scan, as these accounts of how major diseases reshape daily living make clear.

Screening that earns its place

Colonoscopy from around 45 prevents cancer by removing polyps before they turn. Mammography from 40 to 74 catches tumours that can’t be felt. HPV testing has made cervical cancer largely preventable. Low-dose CT screening cuts lung cancer mortality in heavy smokers aged 50 to 80 with a 20 pack-year history.

Screening isn’t risk-free, though. Overdiagnosis is real: some thyroid and prostate tumours found by screening would never have caused symptoms. The honest question isn’t whether screening finds cancer, it’s whether finding it helps.

Questions worth asking your oncologist

Bring a list. The appointment will be shorter than you want.

  • What is the goal here: cure, long-term control, or comfort?
  • What are the expected benefits and the realistic odds for someone like me?
  • Which side effects are likely, which are permanent, and how will we manage them?
  • Is there a clinical trial I qualify for?
  • What is the plan if this treatment stops working?
  • Who do I call at 2am if something goes wrong?

Write down the answers. Ask someone to come with you and take notes. The people who fare best are rarely the ones who understood everything the first time. They’re the ones who kept asking until they did.

You may also like

Leave a Comment